Guy J. Laidig

Composes pour l'inhibition enzymatique

Barry A. Bunin, R. Borchardt, C. Crews, 2005 .

Composes d'inhibition enzymatique

Barry A. Bunin, R. Borchardt, C. Crews, 2005 .

Design and synthesis of an orally bioavailable and selective peptide epoxyketone proteasome inhibitor (PR-047).

S. Demo, M. Aujay, T. Muchamuel, 2009, Journal of medicinal chemistry.

The Selective Proteasome Inhibitor Carfilzomib Is Well Tolerated in Experimental Animals with Dose Intensive Administration

M. Aujay, T. Muchamuel, M. Bennett, 2008 .

Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer

Jennifer B Dennison, S. Demo, M. Bennett, 2014, Molecular Cancer Therapeutics.

Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome.

S. Demo, M. Aujay, M. Bennett, 2007, Cancer research.

Small Molecule Therapeutics Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer

S. Demo, M. Bennett, F. Parlati, 2014 .